Selected Publications

Hivnor C, Shapiro M, Vittorio CC: Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV. Arch Dermatol 140: 13-14, 2004.

McGinnis KS, Junkins-Hopkins JM, Crawford G, Shapiro M, Rook AH, Vittorio CC: Low dose oral bexarotene in combination with low dose interferon alpha in the treatment of cutaneous T-cell lymphoma: Clinical synergism and possible immunologic mechanisms. J Amer Acad Dermatol 50(3): 375-379, 2004.

McGinnis KS, Ubriani R, Newton S, Junkins-Hopkins JM, Vittorio CC, Wysocka M, Rook AH: The addition of interferon gamma to oral bexarotene therapy with photopheresis. Arch Dermatol 141(9): 1176-1178, 2005 Notes:

Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH: Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-Cell lymphoma. J Cutan Med Surg E-pub, September, 2003.

Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH: Extracorporeal Photopheresis and Multimodality Immunomodulatory Therapy in the Treatment of Cutaneous T-Cell Lymphoma. J Cutan Med Surg 2004 Notes: In Press.

Lehrer MS, Crawford G, Gelfand J, Leyden JJ, Vittorio CC: The effect of wax epilation prior to hair removal with a long-pulsed alexandrite laser – a pilot study. J Dermatologic Surg 29: 118-123, 2003.

Prins C, Vittorio C, Padilla RS, Hunziker T, Itin P, Forster J, Brocker ED, Saurat JH, French LE: Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study. Dermatology 207(1): 96-99, 2003.

Gelfand JM, Wasik MA, Vittorio CC, Rook AH, Junkins-Hopkins JM: Progressive epidermotropic primary cutaneous CD30+, CD8+ anaplastic large T-cell lymphoma in a patient with sarcoidosis. J Amer Acad Dermatol 51(2): 304-308, 2004 Notes:

Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ: Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the Hyper-CVAD regimen. Amer J Hematol 74(1): 46-51, 2003.